Middle East Pharmaceutical Industries Company (SASE: 4016)
Health Care · Pharmaceuticals · SA
SR60.50
-1.31% today · -14.6% 1Y
Middle East Pharmaceutical Industries Company (SASE: 4016) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $564.02M.
Over the last twelve months the share price has lost 14.6%, trading between 53.89 and 79.09.
Tweenvest scores Middle East Pharmaceutical Industries Company across four factors: quality 71/100, value 78/100, growth 76/100, dividend 58/100. Its strongest factor is value.
4016 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $564.02M
- Revenue (TTM)
- $136.30M
- P/E
- 19.52
- EPS
- 3.10
- Dividend yield
- 2.29%
- Beta (5Y)
- 0.45
- 52-week high
- SR79.09
- 52-week low
- SR53.89
- Avg volume (3M)
- —
- Shares outstanding
- 35.00M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,239.50 | -0.60% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $273.42 | +0.14% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $155.97 | +3.52% |
| Roche Holding AGSWX: ROP | $368.80B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $28.38 | +1.47% |
Figures last refreshed Aug 18, 2026.